Baropharm

About Baropharm

Baropharm, founded in 2019 by pharmacists Kim Seul-gi and Shin Gyeong-do, operates as a Pharm-Tech company in South Korea. The founders, with over a decade of direct pharmacy management experience each, identified inefficiencies in the pharmaceutical ordering process as a key challenge. This firsthand knowledge led to the creation of an integrated platform to address these operational complexities.

The company's core offering is a B2B platform that allows pharmacies to consolidate their pharmaceutical orders from various wholesalers and drug companies into a single interface. This system, which utilizes scraping technology, is designed to significantly reduce the time and effort pharmacists spend on inventory management. Key features include price and stock comparison across suppliers, a notification service for out-of-stock items, integrated returns management, and data analytics for pharmacy operations. The platform serves a substantial portion of the South Korean market, with over 20,000 pharmacies—approximately 80-90% of the national total—using the service.

Baropharm has expanded its services beyond simple order consolidation to become a comprehensive pharmacy management solution. This includes 'Baro Market' for direct transactions between pharmacies, 'BaroQ' a community feature for pharmacists to exchange information, and private label health-focused products under the 'Our Pharm' brand sold through its subsidiary, BRP Labs. The company is also developing 'Around Pharm', a B2B2C platform to connect pharmacies directly with consumers for services like locating nearby pharmacies and making visit reservations. Revenue is generated through its marketplace offerings, such as 'Baropharm Store' and 'Baropharm Mall', which function as platforms for suppliers to sell to pharmacies.

Financially, Baropharm has demonstrated significant growth, securing over 40 billion KRW (approximately $28.6 million) in cumulative funding. Its investors include notable firms like SoftBank Ventures Asia (SBVA), Mirae Asset Venture Investment, KB Investment, KDB Capital, and CJ Logistics. The company completed a pre-IPO funding round and is preparing for a public offering, aiming to further enhance its digital infrastructure and support projects that increase sales for its partner pharmacies.